We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
76
Costco
COST
$422B
$46.6M 0.32%
103,662
+29,664
+40% +$13M
MS icon
77
Morgan Stanley
MS
$337B
$46.5M 0.32%
478,176
+255,745
+115% +$25.3M
DAR icon
78
Darling Ingredients
DAR
$9.62B
$45.9M 0.31%
638,023
+181,507
+40% +$13M
EQIX icon
79
Equinix
EQIX
$103B
$45.6M 0.31%
57,655
+2,807
+5% +$2.33M
ISRG icon
80
Intuitive Surgical
ISRG
$128B
$45.4M 0.31%
137,154
-564
-0.4% -$189K
CSCO icon
81
Cisco
CSCO
$452B
$44.5M 0.3%
817,934
+101,148
+14% +$5.68M
ADI icon
82
Analog Devices
ADI
$181B
$43.8M 0.3%
261,387
-554
-0.2% -$92.9K
WMS icon
83
Advanced Drainage Systems
WMS
$11B
$43.7M 0.3%
404,122
+40,234
+11% +$4.63M
TX icon
84
Ternium
TX
$9.37B
$43.1M 0.29%
1,019,700
-434,300
-30% -$21.2M
BALL icon
85
Ball Corp
BALL
$17.2B
$42.7M 0.29%
474,680
+51,246
+12% +$4.55M
INTU icon
86
Intuit
INTU
$83.1B
$42.2M 0.29%
78,253
+47,372
+153% +$25.5M
KEYS icon
87
Keysight
KEYS
$53.6B
$41.1M 0.28%
250,462
+45,667
+22% +$7.67M
ASND icon
88
Ascendis Pharma A/S
ASND
$16.6B
$39.9M 0.27%
250,399
-32,581
-12% -$4.46M
VRNS icon
89
Varonis Systems
VRNS
$5.36B
$39.8M 0.27%
654,207
-2,224
-0.3% -$139K
TTEK icon
90
Tetra Tech
TTEK
$8.28B
$39.8M 0.27%
1,331,475
+278,035
+26% +$7.63M
SPGI icon
91
S&P Global
SPGI
$130B
$39.6M 0.27%
93,119
+6,050
+7% +$2.62M
HOLX
92
DELISTED
Hologic
HOLX
$39.5M 0.27%
535,328
+139,145
+35% +$10.4M
XYL icon
93
Xylem
XYL
$28.6B
$38.4M 0.26%
310,611
+12,180
+4% +$1.57M
ABBV icon
94
AbbVie
ABBV
$454B
$37.8M 0.26%
350,787
-1,069
-0.3% -$122K
ARNA
95
DELISTED
Arena Pharmaceuticals Inc
ARNA
$37.3M 0.25%
626,318
XIFR
96
XPLR Infrastructure LP
XIFR
$1.19B
$37M 0.25%
490,486
+49,099
+11% +$3.83M
OLED icon
97
Universal Display
OLED
$3.81B
$37M 0.25%
216,203
+29,755
+16% +$6.16M
SLAB icon
98
Silicon Laboratories
SLAB
$7.17B
$36.6M 0.25%
261,495
+30,126
+13% +$4.52M
IPG
99
DELISTED
Interpublic Group of Companies
IPG
$35.6M 0.24%
970,317
+314,079
+48% +$11.2M
WCN
100
Waste Connections
WCN
$42.7B
$34.9M 0.24%
277,195
+27,427
+11% +$3.47M

Similar funds

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.